Related Experiment Video
Updated: Dec 3, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Successful treatment of pediatric post-liver transplant Kaposi`s sarcoma with paclitaxel
Hilal Susam Şen1, Belen Terlemez Ateş2, Pınar Yılmazbaş2
1Division of Pediatric Oncology, Health Sciences University, Okmeydanı Training and Research Hospital, İstanbul, Turkey.
Background:
Kaposi`s sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients. Unlike adult recipients, KS in pediatric organ transplantation is quite rare. Treatment is usually withdrawal of immunosuppression; non-responders often receive chemotherapy.
Case:
We have reported a child with post-liver transplant visceral KS which has progressed despite withdrawal of immunosuppressive therapy, who has been treated with Paclitaxel for three weeks. KS has regressed completely after four cycles of Paclitaxel.
Conclusion:
Paclitaxel should be considered as an effective first line treatment option for patients with posttransplant KS.
